| Tyler C Gillmen, DO | |
|
555 Duke St, Lancaster, PA 17602-2250 | |
| (717) 544-4676 | |
| (717) 544-7157 |
| Full Name | Tyler C Gillmen |
|---|---|
| Gender | Male |
| Speciality | Anesthesiology |
| Experience | 9 Years |
| Location | 555 Duke St, Lancaster, Pennsylvania |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1336534999 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207L00000X | Anesthesiology | OS019857 (Pennsylvania) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Lancaster General Hospital | Lancaster, PA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Lancaster General Hospital | 1254240039 | 408 |
News Archive
With the approaching national implementation of The Mental Health Parity and Addiction Equity Act on July 1, 2010, members of the Society of Actuaries are providing clarity regarding the law's potential unintended consequences on consumers' existing health insurance plans and benefits. While the law is intended to provide non-discriminatory mental health coverage, members of the SOA are helping consumers and large and small employers understand what effects the law will have on current health plan offerings, and what individuals can do to help avoid higher out-of-pocket costs.
Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) and Neurogen Corporation (NASDAQ:NRGN) announced today they have entered into a definitive merger agreement under which Ligand will acquire Neurogen. Under the transaction, Neurogen stockholders will receive an estimated $11 million in Ligand common stock and will be granted Contingent Value Rights ("CVRs") under four CVR agreements.
An estimated 45 percent of people are at risk of developing knee osteoarthritis (OA) in their lifetime. According to a network meta-analysis research article published in the May 1, 2018 issue of the Journal of the American Academy of Orthopaedic Surgeons, the nonsteroidal anti-inflammatory drug naproxen was ranked most effective in individual knee OA treatment for improving both pain and function, and is considered a relatively safe and low-cost treatment method.
The VOSTARS (‘Video Optical See-Through Augmented Reality surgical System') medical visor is a head-mounted display (HMD) system that is capable of superimposing the patient's x-ray images in perfect 3D unison with their anatomy.
"White House spokesman Robert Gibbs insists the Obama administration has not shifted its goals on health care reform or distanced itself from a government-run public insurance option." He told reporters today that stories indicating the Obama administration was backing away from including the public option in its push to overhaul the health system were "overblown."
› Verified 5 days ago
| Entity Name | Anesthesia Associates Of Lancaster, Ltd. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1780675835 PECOS PAC ID: 4587559224 Enrollment ID: O20040220000219 |
News Archive
With the approaching national implementation of The Mental Health Parity and Addiction Equity Act on July 1, 2010, members of the Society of Actuaries are providing clarity regarding the law's potential unintended consequences on consumers' existing health insurance plans and benefits. While the law is intended to provide non-discriminatory mental health coverage, members of the SOA are helping consumers and large and small employers understand what effects the law will have on current health plan offerings, and what individuals can do to help avoid higher out-of-pocket costs.
Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) and Neurogen Corporation (NASDAQ:NRGN) announced today they have entered into a definitive merger agreement under which Ligand will acquire Neurogen. Under the transaction, Neurogen stockholders will receive an estimated $11 million in Ligand common stock and will be granted Contingent Value Rights ("CVRs") under four CVR agreements.
An estimated 45 percent of people are at risk of developing knee osteoarthritis (OA) in their lifetime. According to a network meta-analysis research article published in the May 1, 2018 issue of the Journal of the American Academy of Orthopaedic Surgeons, the nonsteroidal anti-inflammatory drug naproxen was ranked most effective in individual knee OA treatment for improving both pain and function, and is considered a relatively safe and low-cost treatment method.
The VOSTARS (‘Video Optical See-Through Augmented Reality surgical System') medical visor is a head-mounted display (HMD) system that is capable of superimposing the patient's x-ray images in perfect 3D unison with their anatomy.
"White House spokesman Robert Gibbs insists the Obama administration has not shifted its goals on health care reform or distanced itself from a government-run public insurance option." He told reporters today that stories indicating the Obama administration was backing away from including the public option in its push to overhaul the health system were "overblown."
› Verified 5 days ago
| Entity Name | Lancaster General Hospital |
|---|---|
| Entity Type | Part B Supplier - Hospital Department(s) |
| Entity Identifiers | NPI Number: 1750399507 PECOS PAC ID: 1254240039 Enrollment ID: O20050606000065 |
News Archive
With the approaching national implementation of The Mental Health Parity and Addiction Equity Act on July 1, 2010, members of the Society of Actuaries are providing clarity regarding the law's potential unintended consequences on consumers' existing health insurance plans and benefits. While the law is intended to provide non-discriminatory mental health coverage, members of the SOA are helping consumers and large and small employers understand what effects the law will have on current health plan offerings, and what individuals can do to help avoid higher out-of-pocket costs.
Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) and Neurogen Corporation (NASDAQ:NRGN) announced today they have entered into a definitive merger agreement under which Ligand will acquire Neurogen. Under the transaction, Neurogen stockholders will receive an estimated $11 million in Ligand common stock and will be granted Contingent Value Rights ("CVRs") under four CVR agreements.
An estimated 45 percent of people are at risk of developing knee osteoarthritis (OA) in their lifetime. According to a network meta-analysis research article published in the May 1, 2018 issue of the Journal of the American Academy of Orthopaedic Surgeons, the nonsteroidal anti-inflammatory drug naproxen was ranked most effective in individual knee OA treatment for improving both pain and function, and is considered a relatively safe and low-cost treatment method.
The VOSTARS (‘Video Optical See-Through Augmented Reality surgical System') medical visor is a head-mounted display (HMD) system that is capable of superimposing the patient's x-ray images in perfect 3D unison with their anatomy.
"White House spokesman Robert Gibbs insists the Obama administration has not shifted its goals on health care reform or distanced itself from a government-run public insurance option." He told reporters today that stories indicating the Obama administration was backing away from including the public option in its push to overhaul the health system were "overblown."
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Tyler C Gillmen, DO 555 Duke St, Lancaster, PA 17602-2250 Ph: (717) 544-4676 | Tyler C Gillmen, DO 555 Duke St, Lancaster, PA 17602-2250 Ph: (717) 544-4676 |
News Archive
With the approaching national implementation of The Mental Health Parity and Addiction Equity Act on July 1, 2010, members of the Society of Actuaries are providing clarity regarding the law's potential unintended consequences on consumers' existing health insurance plans and benefits. While the law is intended to provide non-discriminatory mental health coverage, members of the SOA are helping consumers and large and small employers understand what effects the law will have on current health plan offerings, and what individuals can do to help avoid higher out-of-pocket costs.
Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) and Neurogen Corporation (NASDAQ:NRGN) announced today they have entered into a definitive merger agreement under which Ligand will acquire Neurogen. Under the transaction, Neurogen stockholders will receive an estimated $11 million in Ligand common stock and will be granted Contingent Value Rights ("CVRs") under four CVR agreements.
An estimated 45 percent of people are at risk of developing knee osteoarthritis (OA) in their lifetime. According to a network meta-analysis research article published in the May 1, 2018 issue of the Journal of the American Academy of Orthopaedic Surgeons, the nonsteroidal anti-inflammatory drug naproxen was ranked most effective in individual knee OA treatment for improving both pain and function, and is considered a relatively safe and low-cost treatment method.
The VOSTARS (‘Video Optical See-Through Augmented Reality surgical System') medical visor is a head-mounted display (HMD) system that is capable of superimposing the patient's x-ray images in perfect 3D unison with their anatomy.
"White House spokesman Robert Gibbs insists the Obama administration has not shifted its goals on health care reform or distanced itself from a government-run public insurance option." He told reporters today that stories indicating the Obama administration was backing away from including the public option in its push to overhaul the health system were "overblown."
› Verified 5 days ago
Dr. Ashima Arora Vaswani, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 250 College Ave, Lancaster, PA 17603 Phone: 717-358-7349 Fax: 717-291-6734 | |
Casey Joseph Prather, D.O. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 250 College Ave Fl 1, Lancaster, PA 17603 Phone: 717-358-7349 Fax: 717-291-6734 | |
Dr. Salvatore J Astarita, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 133 E Frederick St, Lancaster, PA 17602 Phone: 717-394-9821 Fax: 717-394-0175 | |
Dr. Jon B Turula, MD Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 133 E Frederick St, Lancaster, PA 17602 Phone: 717-394-9821 Fax: 717-394-0175 | |
Dr. Margaret A Motl, MD Anesthesiology Medicare: Medicare Enrolled Practice Location: 133 E Frederick St, Lancaster, PA 17602 Phone: 717-394-9821 Fax: 717-394-0175 | |
Dr. Robert B Falk Jr., MD Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 133 E Frederick St, Lancaster, PA 17602 Phone: 717-394-9821 Fax: 717-394-0175 | |
Dr. Kevin F Slenker, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 133 E Frederick St, Lancaster, PA 17602 Phone: 717-394-9821 Fax: 717-394-0175 |